Neurological disorders are major contributors to death and disability worldwide. The
pathology of injuries and disease processes includes a cascade of events that often involve …

Modern disease-modifying therapies (DMTs) in multiple sclerosis (MS) have variable modes
of action and selectively suppress or modulate the immune system. In this review, we …

Multiple Sclerosis (MS) progresses at an unpredictable rate, but predictions on the disease
course in each patient would be extremely useful to tailor therapy to the individual needs …

Interferon-beta-1a (IFN-β-1a) can diminish the symptoms of relapsing-remitting multiple
sclerosis. Herein, we prepared sustained drug delivery IFN-β-1a-loaded nanoparticles by a …

Background Multiple sclerosis (MS) is a chronic and immune-mediated disease of unknown
etiology and leading to a physical and cognitive disability. Different studies suggest that …

Background: Safety data on disease-modifying therapies (DMTs) for relapsing multiple
sclerosis (RMS) during breastfeeding are limited. Objective: Assess safety outcomes for …

Multiple sclerosis (MS) is an autoimmune-mediated disease that damages the central
nervous system. MS pathophysiological features are not entirely understood, but the …

Oxidative stress (OS) plays an essential role in demyelination and tissue injury related to
pathogenesis of multiple sclerosis (MS). On the other hand, vitamin D (VD) as an antioxidant …

Multiple sclerosis (MS) is an immune-mediated disorder characterized by focal
demyelination and chronic inflammation of the central nervous system (CNS). Although the …

Neurodegeneration, including loss of neurons and axons, is a feature of progressive forms
of multiple sclerosis (MS). The mechanisms underlying neurodegeneration are mostly …